Vical Incorporated Gets $1.5 Million Milestone Payment from Merck & Co., Inc. (JOBS)

Bookmark and Share

Reuters -- Vical Inc said it received a milestone payment of $1.5 million from Merck & Co related to an ongoing early-stage trial of a cancer vaccine based on Vical’s technology.

MORE ON THIS TOPIC